ONO-4538HSC

DRUG2 trials

Sponsors

Ono Pharmaceutical Co. Ltd, Ono Pharmaceutical Co., Ltd.

Conditions

Advanced or Metastatic Solid TumorsPediatric Malignant Solid Tumor and Epithelioid Sarcoma

Phase 1

A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors

Active, not recruitingNCT06548217

Ono Pharmaceutical Co. LtdAdvanced or Metastatic Solid Tumors

Start: 2024-05-07End: 2028-02-29Target: 31Updated: 2025-07-03

A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.

RecruitingNCT07734116

Ono Pharmaceutical Co., Ltd.Pediatric Malignant Solid Tumor and Epithelioid Sarcoma

Start: 2026-08-18End: 2032-02-29Target: 50Updated: 2026-09-08